Patrick Ott, MD, PhD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| NeoVax Plus Ipilimumab in Renal Cell Carcinoma (NCT02950766) | Patrick Ott, MD, PhD | 2019-03-03 |
Track Patrick Ott, MD, PhD automatically
Every clearance here is in the API, with alerts when new ones post.